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1. Introduction1
For migraine (migraine) of the disease, its clinical is a pri-
mary headache types are common, the main clinical mani-
festations of paroxysmal severe headache and headache, 
beating, mostly belonging to the lateral type, time of onset 
usually lasts for four hours to seventy-two hours or so, in 
the course of disease often accompanied by nausea and 
vomiting and other symptoms, in daily life, some irritat-
ing light, sound and other external interference or degree 
of disorder, other daily activities are likely to aggravate 
migraine so, migraine patients need quiet environment 
treatment, the rest of the way to a certain extent, ease the 
patients with migraine headache. And migraine is a com-
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mon chronic neurological disease, the general incidence 
of the group in adolescence or children, and the incidence 
of major female migraine patients, in the course of the in-
vestigation found that the ratio between men and women 
in the clinical incidence of migraine patients is about 3 to 
ten percent, and in a certain extent, there is a genetic phe-
nomenon. And migraine is one of common diseases in the 
Department of internal medicine, due to repeated attacks, 
severe pain, serious impact on the work of migraine pa-
tients, so that the quality of life of migraine patients. We 
use Toutongning capsule combined with Instant Cardio-
reliever pills, metoprolol in the treatment of migraine, ob-
tain satisfactory curative effect [1].
2. Materials and methods
2.1. General information
From March 2008 to December 2013, 150 patients with 
migraine were treated in our hospital. Case selection: (1) 
In line with the 2004 headache classification of the 2nd 
edition of migraine diagnosis standard; (2) Eliminate the 
tension headaches, cluster headache, intracranial pressure 
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headache, intracranial infection etc. primary and second-
ary other headache. 2 weeks before admission, the patients 
were stopped taking all the drugs. The headache symptom 
ratings according to the 1988 International Headache Soci-
ety standard, grade I no pain, grade II mild headache, but 
does not affect the activity, grade III moderate pain, but 
does not stop the activity, grade IV severe pain cannot take 
part in the activity.
2.2. Method
150 cases of migraine were randomly divided into three 
groups, the treatment group (50 cases), given a headache 
Ning Capsule (Xianyang Buchang Pharmaceutical Co., 
Ltd. production) 3 capsules each time, 3 times a day orally; 
Instant Cardio-reliever pills (Tianjin Pharmaceutical Com-
pany production) 10 pills each time, 3 times a day orally; 
metoprolol (Advaita Kang Pharmaceutical Co., Ltd. is the 
production) 25 mg per time, 2 times a day. Control group 
A50 cases, the application of the town of Ning capsules 4 
capsules each time, 3 times a day, 10 capsules each time, 
3 times a day orally. The control group were given meto-
prolol B50 25 mg each time, 2 times a day, each time 10 
mg flunarizine hydrochloride, orally 1 times every night. 3 
groups of migraine patients with a total of 30 days [2].
2.3. Efficacy criteria
According to standard of 2008 edition migraine of neu-
ral disease diagnosis and treatment, after treatment of 
migraine symptoms 2‒5 days eliminated, along with ac-
companying symptoms also eliminate, within 1 year with-
out recurrence is effective, the treatment after symptoms 
disappeared or relieved, only to mental stress and fatigue 
had occasional seizures, and modulating 2−3 days after 
symptoms disappear is effective; the symptoms and signs 
improved slightly, but the onset of frequency and the past 
effect than there are no changes to the invalid.
2.4. Statistical processing
All data were statistically analyzed by SPSS 12.0 software, 
and the t test was used in the treatment of the patients be-
fore and after treatment.
3. Results
3.1. Comparison of three groups of patients with mi-
graine
After 30 days treatment, the effective rate was 72% in the 
treatment group and 56% in the control group, and the 
control group B was 58%. The total effective rate was 94% 
in the treatment group and 72% in the control group, and 
76% in the control group B. The effective rate of the treat-
ment group was significantly higher than that of the con-
trol group, A, B, there was significant difference (p < 0.05), 
the total effective rate was very significant difference com-
pared with the two control groups (p < 0.01), see Table 1 
and Table 2.
3.2. Contrast the data of three groups of the mi-
graine patients before and after treatment 
Compared with before treatment, the treatment group 
showed significant improvement and difference in the 
grading of symptoms (p < 0.05). Showing significant dif-
ference as compared with that before treatment (p < 0.05), 
the control group A and B were also apparently improved. 
Compared with the grading of symptoms of the control 
group A and B, the treatment group’s improvement was 
more significant (p < 0.01). See Table 3.
Table 1. Comparison of the efficacy of A in treatment group and control group [n (%)].
Group n Excellence Effective Invalid Total effective
Treatment group 50 36 (72.00)* 11 (22.00) 3 (6.00) 47 (94.00)**
Control group A 50 28 (56.00) 8 (16.00) 14 (28.00) 36 (72.00)
Note:*p < 0.05, **p < 0.01.
Table 2. Comparison of the efficacy of B in treatment group and control group [n (%)].
Group n Excellence Effective Invalid Total effective
Treatment group 50 36 (72.00)* 11 (22.00) 3 (6.00) 47 (94.00)**
Control group A 50 29 (58.00) 9 (18.00) 12 (24.00) 38 (76.00)
Note:*p < 0.05, **p < 0.01.
Table 3. Comparison of symptom classification of migraine in three groups (x ± s).
Group n
Before treatment After treatment
t p
I II III IV I II III IV
Treatment group 50 0 11 23 16* 42 5 3 0** 9.40 < 0.05
Control group A 50 0 10 24 16 23 17 8 2 6.67 < 0.05
Control group B 50 0 12 23 15 25 13 9 3 4.91 < 0.05
Note: *p > 0.05; **p < 0.01.
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3.3. The recrudescence rate of half a year between 
three groups of the migraine patients
Compared with the control group A and B, the treatment 
group has low recurrence rate, the improvement was so 
significant (p < 0.01). See Table 4.
Table 4. Comparison of half year recurrence rate in migraine 
patients (x ± s).
Group Relapse within half a year Recurrence rate (n%)
Treatment group 4 8
Control group A 9 18
Control group B 11 22
t (A) - 3.20
t (B) - 4.12
p (A) - < 0.01
p (B) - < 0.01
3.4. Adverse reactions
In the course of nursing and clinical investigation of three 
groups of migraine patients, the patients were not found 
adverse reactions in the treatment process.
4. Discussion
Migraine is due to various internal and external factors 
acting on the nerve and blood vessels and the central ner-
vous system and vascular dysfunction. The etiology and 
pathogenesis of this disease is not very clear. There is a 
spasm of the blood vessels during the migraine attack, 
which can lead to cerebral ischemia and nerve function 
damage. Autonomic dysfunction, that is, sympathetic 
and parasympathetic dysfunction [3]. The scientific study 
confirmed that the platelet aggregation of patients with 
migraine is easier to gather, and release adrenaline, nora-
drenaline, peanut four acid and A2. These substances can 
further promote the platelet aggregation, which can produce 
a large number of blood vessels, shrink the blood vessels, 
reduce cerebral blood flow. Toutongning capsule have gas-
trodin, tuckahoe, Radix Polygoni Multiflori, angelica, scor-
pion etc.. The gastrodin can increase in arterial blood flow, 
inhibit platelet aggregation, improve cerebral circulation, 
regulate nerve metabolism, with loose, antispasmodic effect 
on arterial smooth muscle, can regulate vasomotor func-
tion, alleviate headache; tuckahoe has analgesic effect; Radix 
Polygoni Multiflori with lipid with Angelica; antioxidation, 
platelet aggregation, inhibition the role of free radicals; the 
scorpion can pass through the blood brain barrier, directly 
on the site with headache, antispasmodic and analgesic ef-
ficacy of strong; Instant Cardio-reliever pills oral rapid on-
set, the main ingredients of Rhizoma Chuanxiong, borneol, 
mechanism of treating migraine is blood stasis, blood ves-
sels, relieve vascular spasm, reduce vascular resistance, im-
prove microcirculation, reduce the capillary permeability, 
the platelet aggregation and adsorption capacity decreased, 
reducing blood viscosity [4,5]. Metoprolol early inhibition of 
migraine cortical surface arteriolar spasm, vascular dilation 
and exacerbation can inhibit beta receptor mediated inhibi-
tion of migraine, nerve excitability enhancement, balance, 
regulating sympathetic parasympathetic nerve function, the 
combination of three drugs, with the combination of Chi-
nese and Western medicine, complementary and mutual as-
sistance at the same time, taking into account all the major 
aspects of migraine, ensure the treatment of missing points, 
does not exist in the process of treatment of migraine in 
this way, not only to a certain extent, can quickly relieve mi-
graine pain, but also good effect on consolidation, enhance 
the patient’s own ability to resist disease, greatly reduce the 
recurrence rate, Co good effect, no obvious adverse reac-
tions, the treatment for it has played a key role, but also an 
innovation of new treatment methods.
5. Conclusion
As mentioned above, in the clinical, the incidence of mi-
graine between men and women is about 1:2−3, the preva-
lence of the population is about five percent to ten percent, 
and to some extent, the phenomenon of genetic. Migraine 
is a neurological department of internal medicine and one 
of the common diseases, due to recurrent, severe pain, mi-
graine patients seriously affect the work and study, so the 
need for appropriate treatment of, through clinical research 
found that, for the treatment of migraine, Toutongning 
capsule combined with available Kyushin Pills, metoprolol 
in the treatment of migraine curative effect is relatively sig-
nificant, can effectively control the headache, to maximize 
the quality of life of patients with migraine, and in the 
process of drug use, drug side effects caused by the small, 
and can be quickly for the treatment of migraine, and high 
safety, repeated phenomenon is not easy to appear, for the 
cure of migraine ills, it provides a new way of thinking, is 
the gospel of migraine patients.
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